An ongoing FMT clinical trial (NCT05273255) being conducted at the University Hospital Zurich (Zurich, Switzerland), encompassing multiple solid tumors including PCa, aims to restore treatment sensitivity in recipients by altering their gut microbiota, thereby identifying specific microbial strains that could be utilized for future personalized therapies
Repairs stomach lining and intestinal barrier
Ainda no h previso de quando deve chegar ao mercado.
Storing the powder in a fridge for months is a gamble, and in research, we don't gamble
Within the cell population, liraglutide treatment increased the -2 and -3 subclusters and decreased the -1 subcluster
Giugliano D, Longo M, Caruso P, Maiorino MI, Bellastella G, Esposito K (2021) Sodium-glucose co-transporter-2 inhibitors for the prevention of cardiorenal outcomes in type 2 diabetes: an updated meta-analysis